PRMT1 and esophageal squamous cell carcinoma: Likewise, PRMT1 was found to be overexpressed in triple negative breast cancer (TNBC) and oesophageal squamous cell carcinoma (ESCC) (Suresh et al., 2022; Zhao et al., 2019).